Smith And Kenner Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.60 Cr
as on 13-12-2024
- Paid Up Capital ₹ 2.12 Cr
as on 13-12-2024
- Company Age 38 Year, 7 Days
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 4.39 Cr
as on 13-12-2024
About Smith And Kenner Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 2.60 Cr and a paid-up capital of Rs 2.12 Cr.
The company currently has active open charges totaling ₹4.39 Cr.
Jayswamy Sesham and Sobha Sesham serve as directors at the Company.
- CIN/LLPIN
U24230TG1987PTC007087
- Company No.
007087
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 1987
- Date of AGM
28 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Smith And Kenner Pharmaceuticals Pvt Ltd offer?
Smith And Kenner Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Cardiac Drugs, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Pain Killers, Anti Infective Agent, Anti Infective Tablet, Diabetes Medicine, Glimepride Tablets.
Who are the key members and board of directors at Smith And Kenner Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayswamy Sesham  | Managing Director | 09-Jan-1987 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sobha Sesham | Director | 09-Jan-1987 | Current |
Financial Performance of Smith And Kenner Pharmaceuticals.
Enhance accessibility to Smith And Kenner Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Smith And Kenner Pharmaceuticals?
Unlock access to Smith And Kenner Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
A.P.S.F.C. Creation Date: 15 May 2001 | ₹0.60 M | Open |
State Bank Of India Creation Date: 13 Aug 1991 | ₹1.50 M | Open |
State Bank Of India Creation Date: 25 Mar 1990 | ₹0.50 M | Open |
How Many Employees Work at Smith And Kenner Pharmaceuticals?
Unlock and access historical data on people associated with Smith And Kenner Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smith And Kenner Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smith And Kenner Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
